Nico Gagelman is a physician and scientist who co-founded and co-chairs the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, and he also serves as the chair of the EBMT subcommittee focused on CAR-T cell therapies for plasma cell disorders.
His work is particularly impactful in the realm of CAR-T treatments for multiple myeloma, where he has contributed to advancing research and clinical approaches.
Recently Nico Gagelmann began a new series on X titled ‘Let’s Learn Hematology in 2025.’ Here’s part 2 of his educational journey:
“Differential of anemia, simplified.”
“Causes of bleeding, simplified.”
“First description of sickle cell disease in 1910.”
“Drug approvals in hematology in 2024.”
“Anemia management in older patients.”
“Erdheim-Chester disease features.”
“Human leukocyte antigen complex.”
